Price · as of 2026-09-04
$1.91
Market cap 18.76M
Price history
| Week | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 7, 2025 – Apr 11, 2025 | $4.82 | $14.85 | $4.71 | $14.70 | 0 |
| Apr 14, 2025 – Apr 17, 2025 | $15.18 | $25.53 | $14.40 | $17.04 | 0 |
| Apr 21, 2025 – Apr 25, 2025 | $16.10 | $21.00 | $15.80 | $18.85 | 0 |
| Apr 28, 2025 – May 2, 2025 | $19.19 | $28.50 | $17.85 | $26.73 | 0 |
| May 5, 2025 – May 9, 2025 | $26.50 | $28.55 | $23.31 | $25.61 | 0 |
| May 12, 2025 – May 16, 2025 | $25.26 | $28.09 | $25.16 | $25.23 | 0 |
| May 19, 2025 – May 23, 2025 | $25.01 | $34.31 | $25.00 | $29.09 | 0 |
| May 26, 2025 – May 30, 2025 | $32.00 | $33.95 | $28.10 | $28.34 | 0 |
| Jun 2, 2025 – Jun 6, 2025 | $30.21 | $31.22 | $24.02 | $28.50 | 0 |
| Jun 9, 2025 – Jun 13, 2025 | $29.45 | $29.45 | $24.62 | $24.62 | 0 |
| Jun 16, 2025 – Jun 20, 2025 | $24.62 | $26.71 | $24.36 | $25.77 | 0 |
| Jun 23, 2025 – Jun 27, 2025 | $25.99 | $28.73 | $23.89 | $24.61 | 0 |
| Jun 30, 2025 – Jul 3, 2025 | $24.61 | $24.61 | $21.14 | $22.46 | 0 |
| Jul 7, 2025 – Jul 11, 2025 | $22.16 | $27.79 | $21.14 | $27.35 | 0 |
| Jul 14, 2025 – Jul 18, 2025 | $27.99 | $31.98 | $22.30 | $24.61 | 0 |
| Jul 21, 2025 – Jul 25, 2025 | $24.48 | $28.75 | $24.42 | $26.52 | 0 |
| Jul 28, 2025 – Aug 1, 2025 | $26.16 | $27.05 | $24.30 | $26.20 | 0 |
| Aug 4, 2025 – Aug 8, 2025 | $26.34 | $27.76 | $22.40 | $23.93 | 0 |
| Aug 11, 2025 – Aug 15, 2025 | $23.78 | $25.00 | $22.74 | $24.00 | 0 |
| Aug 18, 2025 – Aug 22, 2025 | $23.93 | $29.00 | $23.79 | $28.05 | 0 |
| Aug 25, 2025 – Aug 29, 2025 | $28.40 | $31.54 | $27.52 | $29.92 | 0 |
| Sep 1, 2025 – Sep 5, 2025 | $29.88 | $31.88 | $28.20 | $31.11 | 0 |
| Sep 8, 2025 – Sep 12, 2025 | $31.11 | $36.71 | $29.33 | $33.88 | 0 |
| Sep 15, 2025 – Sep 19, 2025 | $33.94 | $40.77 | $33.51 | $38.24 | 0 |
| Sep 22, 2025 – Sep 26, 2025 | $37.51 | $39.69 | $35.15 | $36.32 | 0 |
| Sep 29, 2025 – Oct 3, 2025 | $36.85 | $41.00 | $34.66 | $40.23 | 0 |
| Oct 6, 2025 – Oct 10, 2025 | $39.98 | $43.65 | $39.13 | $41.60 | 0 |
| Oct 13, 2025 – Oct 17, 2025 | $6.20 | $7.23 | $5.65 | $6.58 | 0 |
| Oct 20, 2025 – Oct 24, 2025 | $6.40 | $6.43 | $4.90 | $4.97 | 0 |
| Oct 27, 2025 – Oct 31, 2025 | $4.96 | $5.00 | $4.48 | $4.65 | 0 |
| Nov 3, 2025 – Nov 7, 2025 | $4.60 | $4.79 | $3.85 | $4.02 | 0 |
| Nov 10, 2025 – Nov 14, 2025 | $4.01 | $4.45 | $3.89 | $4.03 | 0 |
| Nov 17, 2025 – Nov 21, 2025 | $4.01 | $4.20 | $3.78 | $3.92 | 0 |
| Nov 24, 2025 – Nov 28, 2025 | $3.90 | $4.18 | $3.85 | $4.12 | 0 |
| Dec 1, 2025 – Dec 5, 2025 | $4.12 | $4.40 | $3.74 | $4.18 | 0 |
| Dec 8, 2025 – Dec 12, 2025 | $4.18 | $4.71 | $4.05 | $4.41 | 0 |
| Dec 15, 2025 – Dec 19, 2025 | $4.41 | $4.44 | $3.83 | $3.98 | 0 |
| Dec 22, 2025 – Dec 26, 2025 | $3.97 | $4.14 | $3.90 | $4.14 | 0 |
| Dec 29, 2025 – Jan 2, 2026 | $4.14 | $4.46 | $3.96 | $4.08 | 0 |
| Jan 5, 2026 – Jan 9, 2026 | $4.09 | $4.70 | $3.87 | $4.55 | 0 |
| Jan 12, 2026 – Jan 16, 2026 | $4.55 | $4.75 | $4.25 | $4.57 | 0 |
| Jan 19, 2026 – Jan 23, 2026 | $4.48 | $4.89 | $4.39 | $4.69 | 0 |
| Jan 26, 2026 – Jan 30, 2026 | $4.64 | $4.64 | $3.84 | $3.97 | 0 |
| Feb 2, 2026 – Feb 6, 2026 | $3.94 | $4.44 | $3.50 | $3.72 | 0 |
| Feb 9, 2026 – Feb 13, 2026 | $3.75 | $4.05 | $3.57 | $3.72 | 0 |
| Feb 16, 2026 – Feb 20, 2026 | $3.81 | $3.89 | $3.51 | $3.64 | 0 |
| Feb 23, 2026 – Feb 27, 2026 | $3.58 | $4.16 | $3.51 | $3.99 | 0 |
| Mar 2, 2026 – Mar 6, 2026 | $3.97 | $4.22 | $3.80 | $3.93 | 0 |
| Mar 9, 2026 – Mar 13, 2026 | $3.90 | $4.00 | $3.61 | $3.92 | 0 |
| Mar 16, 2026 – Mar 20, 2026 | $3.98 | $4.04 | $3.38 | $3.52 | 0 |
| Mar 23, 2026 – Mar 27, 2026 | $3.60 | $3.75 | $3.15 | $3.17 | 0 |
| Mar 30, 2026 – Apr 2, 2026 | $3.08 | $3.28 | $2.81 | $3.02 | 0 |
| Apr 6, 2026 – Apr 10, 2026 | $3.01 | $3.08 | $2.75 | $2.90 | 0 |
| Apr 13, 2026 – Apr 17, 2026 | $3.00 | $3.50 | $2.84 | $3.39 | 0 |
| Apr 20, 2026 – Apr 24, 2026 | $3.38 | $3.38 | $2.91 | $3.10 | 0 |
| Apr 27, 2026 – May 1, 2026 | $3.08 | $3.22 | $3.00 | $3.14 | 0 |
| May 4, 2026 – May 8, 2026 | $3.12 | $4.34 | $3.12 | $4.18 | 0 |
| May 11, 2026 – May 15, 2026 | $3.95 | $4.18 | $3.83 | $4.00 | 0 |
| May 18, 2026 – May 22, 2026 | $3.97 | $4.06 | $3.42 | $3.57 | 0 |
| May 25, 2026 – May 29, 2026 | $3.57 | $3.59 | $3.25 | $3.38 | 0 |
| Jun 1, 2026 – Jun 5, 2026 | $3.38 | $3.45 | $2.78 | $2.89 | 0 |
| Jun 8, 2026 – Jun 12, 2026 | $3.05 | $3.08 | $2.61 | $2.64 | 0 |
| Jun 15, 2026 – Jun 18, 2026 | $2.64 | $2.79 | $2.48 | $2.63 | 0 |
| Jun 22, 2026 – Jun 26, 2026 | $2.66 | $2.75 | $1.50 | $1.50 | 0 |
| Jun 29, 2026 – Jul 2, 2026 | $1.82 | $2.19 | $1.66 | $2.02 | 0 |
| Jul 6, 2026 – Jul 10, 2026 | $1.95 | $5.69 | $1.95 | $3.28 | 0 |
| Jul 13, 2026 – Jul 17, 2026 | $3.20 | $3.45 | $2.88 | $3.20 | 0 |
| Jul 20, 2026 – Jul 24, 2026 | $3.16 | $3.17 | $2.45 | $2.51 | 0 |
| Jul 27, 2026 – Jul 31, 2026 | $2.49 | $2.69 | $2.00 | $2.10 | 0 |
| Aug 3, 2026 – Aug 7, 2026 | $2.09 | $2.09 | $1.80 | $1.87 | 0 |
| Aug 10, 2026 – Aug 14, 2026 | $1.87 | $2.04 | $1.70 | $1.90 | 0 |
| Aug 17, 2026 – Aug 21, 2026 | $1.94 | $2.01 | $1.79 | $1.86 | 0 |
| Aug 24, 2026 – Aug 28, 2026 | $1.87 | $1.92 | $1.76 | $1.82 | 0 |
| Aug 31, 2026 – Sep 4, 2026 | $1.82 | $1.92 | $1.75 | $1.91 | 0 |
Valuation
| Metric | Value | Upside |
|---|---|---|
| IC Value | $5.90 | +209% |
| P/E | -1.60 | |
| P/B | 1.39 | |
| P/S | — | |
| EV/EBITDA | 0.08 | |
| PEG | — | |
| P/TBV | 1.41 |
Valuation history
Annual price overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | IC | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2011 | |||||
| 2012 | |||||
| 2013 | |||||
| 2014 | |||||
| 2015 | |||||
| 2016 | |||||
| 2017 | |||||
| 2018 | |||||
| 2019 | |||||
| 2020 | $694.80 | ||||
| 2021 | $435.24 | $306.89 | |||
| 2022 | $218.16 | $96.92 | |||
| 2023 | $35.32 | $34.36 | |||
| 2024 | $14.76 | $58.88 | |||
| 2025 | $3.92 |
Historic valuation ratios
Pick a category, then toggle metrics to compare.
Line items
Line items
Line items
About Tvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
- CEO
- Imran Alibhai
- Employees
- 12
- Beta
- 0.39
Scroll horizontally for additional metrics. Ticker column stays fixed.
| Basic Info | IC Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | Value | Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| TVRD | Tvardi Therapeutics, Inc. | $1.87 | 18.76M | $5.90 | +216% | -1.60 | 1.39 | — | 0.08 | — | 1.41 | 0.00% | 0.00% | 0.00% | -222.76% | 693.67% | -47.99% | 0.01 | — | 2.86 | 2.79 | 1.13 | -93.00% | -100.00% | -62.08% | -80.80% | -2.13 | 609.41% | 0.00% | 0.00% | 93.11% | 0.06 | 0.06 | — | -5.24 |
| CALC | CalciMedica, Inc. | $0.74 | 11.67M | — | — | -421.47 | -1876.13 | — | -443.37 | -685.59 | -1876.13 | 0.00% | 0.00% | 0.00% | -761.02% | 325.28% | -177.10% | -1.46 | -16.26 | 3.58 | 3.44 | 0.06 | 61.48% | — | 0.25% | -0.17% | -5.60 | 298.34% | 0.00% | 0.00% | 0.00% | -538.73 | -587.38 | — | 345.24 |
| ELUT | Elutia Inc | $0.87 | 38.55M | $28.27 | +3,141% | 0.84 | 1.62 | 3.64 | -1.45 | — | 1.71 | 53.66% | -149.78% | 434.23% | -574.35% | 114.11% | 108.41% | 0.40 | 47.58 | 2.22 | 2.03 | 1.87 | -57.53% | -49.57% | 100.27% | -104.37% | -1.78 | 289.34% | 0.00% | 0.00% | 82.00% | -1.06 | -0.42 | 1.59 | -3.37 |
| LTRN | Lantern Pharma Inc. | $2.80 | 35.73M | — | — | -1.52 | 3.99 | — | -5.52 | — | 3.99 | 0.00% | 0.00% | 0.00% | -123.51% | -49.68% | -93.53% | 12.02 | — | 2.40 | 2.25 | -4.33 | -99.92% | — | -12.04% | -60.20% | -3.48 | -43.33% | 0.00% | 0.00% | 0.00% | -5.25 | -6.03 | — | -13.04 |
| PDSB | PDS Biotechnology Corpora… | $0.73 | 40.64M | — | — | 0.00 | 3.16 | — | -0.64 | — | 3.16 | 0.00% | 0.00% | 0.00% | -244158.22% | 4384.86% | -90953.88% | 1.83 | -5.91 | 2.98 | 2.82 | 0.32 | -28.16% | — | 79057.52% | -94818.77% | -2926.44 | 3988570.09% | 0.00% | 0.00% | 0.00% | -0.62 | 0.00 | — | -11.79 |
| TPST | Tempest Therapeutics, Inc… | $0.91 | 4.06M | — | — | -0.36 | 1.41 | — | -0.38 | -0.11 | 1.41 | 0.00% | 0.00% | 0.00% | -203.63% | -469.32% | -89.91% | 1.22 | -128.38 | 2.50 | 2.33 | -0.02 | 322.00% | — | -19.85% | -285.98% | -8.09 | -473.64% | 0.00% | 0.00% | 0.00% | -0.37 | -0.37 | — | -23.58 |
| XLO | Xilio Therapeutics, Inc. | $9.11 | 59.9M | $52.26 | +474% | -17.04 | 16.92 | 13.64 | -13.92 | — | 16.92 | 96.48% | -95.92% | -80.05% | -132.53% | 67.25% | -31.04% | 0.20 | — | 2.58 | 2.53 | 3.90 | -72.54% | 589.88% | -70.08% | -0.92% | -0.09 | 8.83% | 0.00% | 0.00% | 13.98% | -11.11 | -84.62 | 10.65 | -0.72 |
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($5.90 ÷ $1.91) − 1 = +208.9% (IC, example).